Alicaforsen ( DrugBank: Alicaforsen )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
97	潰瘍性大腸炎	2

96. クローン病

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00048113 (ClinicalTrials.gov)	January 10, 2001	24/10/2002	Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease	ISIS 2302-CS20, Phase 3 Double-Masked, Placebo-Controlled Study of Alicaforsen(ISIS 2302), an Antise ...	Crohn's Disease	Drug: Alicaforsen	Ionis Pharmaceuticals, Inc.	NULL	Completed	12 Years	N/A	All	150	Phase 3	United States;Canada

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00063830 (ClinicalTrials.gov)	April 3, 2003	7/7/2003	ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicafo ...	ISIS 2302-CS27, Phase 2, Double-Blinded, Controlled Study of Four Dosing Regimens of Alicaforsen(ISI ...	Ulcerative Colitis	Drug: Alicaforsen	Ionis Pharmaceuticals, Inc.	NULL	Completed	18 Years	N/A	All		Phase 2	United States
2	NCT00063414 (ClinicalTrials.gov)	November 20, 2002	25/6/2003	ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicafor ...	ISIS 2302-CS22, Phase II, Double-Blinded, Active-Controlled Study of Alicaforsen(ISIS 2302) Enema, a ...	Ulcerative Colitis	Drug: Alicaforsen	Ionis Pharmaceuticals, Inc.	NULL	Completed	18 Years	N/A	All		Phase 2	United States